Newsroom

Sorted by: Latest

-

VinFast VF9: The Electric SUV Making Luxury Work for Real Life

MARKHAM, Ontario--(BUSINESS WIRE)--The seven-seat VinFast VF 9 is reshaping what luxury means for Canadian drivers, pairing full-size electric power with calm, lounge-like comfort that turns everyday travel into something quietly indulgent. Full-size electric SUVs are still a relatively rare sight in Canada. Most electric models are compact or mid-sized crossovers, built for commutes rather than cross-country family trips. Few can carry seven adults and their winter luggage without compromise....
-

Avitia Spearheads Advanced Liquid Biopsy Cancer Testing Ecosystem in Thailand with The Chitrapatima Foundation

BANGKOK--(BUSINESS WIRE)--Avitia spearheads advanced liquid biopsy cancer testing in Thailand with The Chitrapatima Foundation, bringing first AI-LBx diagnostics to the region....
-

Licensing Deals in Pharmaceuticals: Analysis of Deal Trends Through 2020-2025 with Financials Terms - Upfront, Milestone, Royalties - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Licensing Deals in Pharmaceuticals 2020-2025" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Pharmaceuticals provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully revised and updated, the report provides details of licensing deals from 2020 to 2025. The report provides the reader with the following key benefits: Understand deal trends since 2020 Browse licensing deals Benchmark analysis...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 10.11.2025 GMAY.LN IE000P0FL8E3 1,050,002.00 USD 39,757,965.88 37.865  ...
-

Qorium獲得2200萬歐元投資,將加快培養皮革商業化進程

荷蘭馬斯垂克--(BUSINESS WIRE)--(美國商業資訊)-- 荷蘭開創性培養皮革生物科技公司Qorium今日宣布,已從Invest-NL和LIOF以及現有投資人Brightlands Venture Partners和Sofinnova Partners處獲得2200萬歐元投資。一批頗具影響力的高淨值個人也參與了本輪融資,其中Invest-NL的投資是依據歐盟委員會InvestEU擔保計畫進行。 隨著市場對穩定、高品質真皮的需求不斷成長,培養皮革市場可望快速擴張。Qorium的技術僅需少量動物細胞就能生產出美觀、均勻的真皮,無需養殖牲畜,同時還能改善最終皮革產品品質、減少生產廢棄物,相較動物源皮革可顯著降低環境影響。 最新的這輪融資是在800萬歐元種子輪融資的基礎上進行的,代表Qorium從科學突破邁向商業落地的又一重要里程碑。目前該公司已成功生產出永續真皮,正在馬斯垂克生產基地安裝新的生物反應器系統,並建立了多項商業合作夥伴關係。憑藉這筆A輪融資,Qorium可望實現規模化生產。 Qorium執行長Michael Newton表示:「這筆投資是對我們變革皮革產業使命投下的強...
-

Melqart Asset Management UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)     1 KEY INFORMATION   (a) Full name of discloser: MELQART ASSET MANAGEMENT (UK) LTD (b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and benefic...
-

Qorium获得2200万欧元投资,将加速培养皮革商业化进程

荷兰马斯特里赫特--(BUSINESS WIRE)--(美国商业资讯)-- 荷兰开创性培养皮革生物科技公司Qorium今日宣布,已从Invest-NL和LIOF以及现有投资者Brightlands Venture Partners和Sofinnova Partners处获得2200万欧元投资。一批颇具影响力的高净值个人也参与了本轮融资,其中Invest-NL的投资是在欧盟委员会InvestEU担保计划下进行的。 随着市场对品质稳定、高质量真皮的需求不断增长,培养皮革市场预计将快速扩张。Qorium的技术仅需少量动物细胞就能生产出美观、均匀的真皮,无需养殖牲畜,同时还能优化最终皮革产品品质、减少生产废弃物,与动物源皮革相比可显著降低环境影响。 最新的这轮融资是在800万欧元种子轮融资的基础上进行的,标志着Qorium从科学突破迈向商业落地的又一重要里程碑。目前该公司已成功生产出可持续真皮,正在马斯特里赫特生产基地安装新的生物反应器系统,并建立了多项商业合作伙伴关系。借助这笔A轮融资,Qorium有望实现规模化生产。 Qorium首席执行官Michael Newton表示:“这笔投资是对我...
-

Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program

WATERTOWN, Mass. & STEVENAGE, England--(BUSINESS WIRE)--Dyno Therapeutics and Trisk Bio announce strategic manufacturing partnership through expanded Frontiers Program...
-

Dyno Therapeutics Unveils Best-in-Class Dyno-bn8 AAV Vector for Muscle Gene Therapies, Achieving Therapeutic Delivery With Improved Safety Potential

WATERTOWN, Mass.--(BUSINESS WIRE)--Dyno Therapeutics unveils best-in-class Dyno-bn8 AAV vector for muscle gene therapies, achieving therapeutic delivery with improved safety potential...
-

Identitätssicherheit versagt bei 75 % der deutschen Unternehmen: RSA ID IQ-Bericht enthüllt die größten Identitätsbedrohungen

BERLIN--(BUSINESS WIRE)--Ein neuer globaler Bericht von RSA, dem führenden Anbieter von Sicherheitslösungen für Identitäten, zeigt, dass Identitätsdiebstahl in diesem Jahr zu häufigeren und kostspieligeren Datenverstößen geführt hat als im Vorjahr. Der 2026 RSA ID IQ Report enthält wichtige Erkenntnisse von mehr als 2.100 Fachleuten aus den Bereichen Cybersicherheit, Identitäts- und Zugriffsmanagement (IAM) und IT darüber, wie häufig Identitätsprobleme in Unternehmen auftreten, welche finanziel...